584 results on '"Blankson, Joel N."'
Search Results
2. Discordant performance of mpox serological assays
3. SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
4. Monocyte-derived macrophages contain persistent latent HIV reservoirs
5. Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones
6. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses
7. Highly Attenuated Infection With a Vpr-Deleted Molecular Clone of Human Immunodeficiency Virus-1
8. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
9. Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes
10. Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA
11. Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls.
12. Discordant Performance of Mpox Serological Assays
13. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2
14. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.
15. Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls
16. Immunology of Latent HIV Infection
17. The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir
18. Failure to Identify HIV-Infected Individuals in a Clinical Trial Using a Single HIV Rapid Test for Screening
19. Immune Responses in Controllers of HIV Infection.
20. Immune Responses in Controllers of HIV Infection
21. T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses
22. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients
23. Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage
24. Heterologous versus homologous boosting regimens elicit qualitatively distinct, BA.5 cross reactive T cells in transplant recipients
25. Altered antibody profiles after receipt of third dose SARS-CoV-2 mRNA vaccines in solid organ transplant recipients
26. Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention
27. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.
28. 354 - Pathobiology of Human Immunodeficiency Viruses
29. Elite suppressors have low frequencies of intact HIV-1 proviral DNA
30. How elite controllers and posttreatment controllers inform our search for an HIV-1 cure
31. SARS-CoV-2 mRNA vaccines induce broad [CD4.sup.+] T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
32. Functional characterization of [CD4.sup.+] T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
33. HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells
34. Bivalent COVID Vaccines; Can the Original Antigenic Sin be Forgiven?
35. SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations.
36. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads
37. A tribute to John G. Bartlett, MD (1937-2021)
38. Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
39. Finding a Cure for Human Immunodeficiency Virus-1 Infection
40. SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations
41. Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature
42. Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
43. Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients
44. The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir
45. Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults
46. Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV
47. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
48. SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
49. SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
50. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.